focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.
Its my understanding that Activ 2 enables consideration to be given to other data already obtained, and that they are looking for something which is delivered directly to the lungs. We know it works and its safe so I'm hoping a broarder common sense approach is taken, progressing us to 3.
https://www.reuters.com/article/health-coronavirus-eu-drugs-idUSS8N2K3081
https://twitter.com/CRSNG_NSERC/status/1388855913977720832?s=20
https://twitter.com/MARYau_MCU_PH/status/1388062720554151937?s=20
Not seen this before, sorry if previously posted. Putting it up before putting under any scrutiny.
http://metaevidence.org/viewPathology2.aspx?selPage=0&selfocus=0&exposition=517&pathology=95&domain=12&endpoints=386,387,441
@Mary has said on twitter today
Concept validated by sng001, and the rational.
The expected effects, if taken early enough, are 80% less intubation (sng), 50% less mortality (China retrospective).
Producing reliable data confirming or disproving the subject is important
https://twitter.com/AimInvestments/status/1378906057800511492?s=20